Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Patient
100%
Hospital
53%
Kidney Graft
39%
Inpatient
34%
Vaccine
32%
COVID-19
31%
Incidence
26%
Cohort Effect
23%
Carbapenem
23%
Tuberculosis
18%
Personnel
18%
Prospective Study
17%
Cellular Immunity
17%
Exanthem
15%
Randomized Controlled Trial
15%
Surgical Infection
15%
Therapeutic Procedure
15%
Disease
14%
COVID-19 Vaccination
13%
Transplantation
12%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Analysis
11%
COVID-19 Vaccine
10%
Hospital Infection
9%
Cell Count
9%
Tertiary Care
9%
Threat
9%
Booster Dose
9%
Antibiotic Resistance
9%
Health
9%
Screening
8%
Specimen
8%
Urinary Tract Infection
8%
Bacterium
8%
Kidney Transplantation
8%
Health Care
7%
Mantoux Test
7%
Retrospective Study
7%
Acinetobacter Baumannii
7%
Drug
7%
Relapse
7%
Health Care Cost
7%
End Stage Renal Disease
7%
Catheter Infection
7%
Antibiotic Therapy
7%
Thyroid Gland
7%
Humoral Immunity
7%
Immunization
7%
Cephalosporin
7%
Abscess
7%
Immunology and Microbiology
Transplant Procedure
36%
Kidney
33%
Vaccine Efficacy
33%
Gene
30%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Minimum Inhibitory Concentration
20%
Immunogenicity
18%
Adoptive Immunity
17%
Prevalence
16%
COVID-19
15%
Influenza A Virus (H1N1)
15%
Kidney Transplantation
14%
Sample
11%
Antimicrobial Resistance
11%
Gram-Positive Bacteria
9%
Booster Dose
9%
Reverse Transcription Polymerase Chain Reaction
9%
Fever
9%
Spectrum
9%
Viral Shedding
8%
Time
8%
Enterobacteriaceae
7%
Enterobacterales
7%
Polymerase Chain Reaction
7%
Human Immunodeficiency Virus 1
7%
Loop-Mediated Isothermal Amplification
7%
Reverse Transcriptase
7%
Humoral Immunity
7%
Influenza
7%
Immunoglobulin M Deficiency
7%
CD4 Lymphocyte Count
7%
Viral Load
7%
Viral Disease
7%
Adenoviridae
7%
Pyrosequencing
7%
Klebsiella pneumoniae
7%
Severe Acute Respiratory Syndrome
7%
Peptoclostridium difficile
7%
Clostridium
7%
Burkholderia Cepacia Complex
7%
Staphylococcus aureus
6%
Monospecific Antibody
6%
Polymerase Chain Reaction
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
36%
Diseases
27%
Acinetobacter Baumannii
23%
Antibiotics
20%
Infection
18%
Gram Positive Bacterium
15%
Coronavirinae
15%
Antiinfective Agent
14%
Oseltamivir
13%
RNA
11%
Vancomycin
10%
Antimicrobial Resistance
8%
Prospective Cohort Study
8%
Drug Capsule
7%
Influenza
7%
Tigecycline
7%
Occupational Exposure
7%
Epidemiology
7%
Pharmacokinetics
7%
Ketolide
7%
Clavulanic Acid
7%
Genetic Epidemiology
7%
Amoxicillin
7%
Clostridium Difficile Infection
7%
Moxifloxacin
7%
Antibiotic Therapy
7%
Dalfopristin Plus Quinupristin
7%
Erythromycin
7%
Sultamicillin
7%
Escherichia Coli Pneumonia
7%
Bioequivalence
7%
Burkholderia Cepacia Complex
7%
Clostridium
5%
Gentamicin
5%
Cryptococcosis
5%